Medchemexpress LLC Elzovantinib | 2271119-26-5 | 99.9% | 409.42 | 100 MG

Supplier:  Medchemexpress LLC HY111787100MG

Elzovantinib (TPX-0022) is an oral-active inhibitor targeting SRC, MET, and c-FMS. It effectively suppresses MET autophosphorylation and downstream signaling pathways such as STAT3, ERK, and AKT in various cell lines. In in-vivo studies, Elzovantinib has demonstrated significant tumor regression and inhibition of tumor growth without causing body weight loss.

• Oral-active inhibitor
• Targets SRC, MET, and c-FMS
• Suppresses MET autophosphorylation and downstream signaling
• Demonstrates tumor regression in animal models
• Inhibits tumor growth
• No body weight loss observed in treated mice

Catalog No. 50-004-38026